326 related articles for article (PubMed ID: 33919368)
1. The Role of Sarcopenic Obesity in Cancer and Cardiovascular Disease: A Synthesis of the Evidence on Pathophysiological Aspects and Clinical Implications.
Silveira EA; da Silva Filho RR; Spexoto MCB; Haghighatdoost F; Sarrafzadegan N; de Oliveira C
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919368
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men.
Atkins JL; Whincup PH; Morris RW; Lennon LT; Papacosta O; Wannamethee SG
J Am Geriatr Soc; 2014 Feb; 62(2):253-60. PubMed ID: 24428349
[TBL] [Abstract][Full Text] [Related]
3. Sarcopenic obesity as a determinant of cardiovascular disease risk in older people: a systematic review.
Evans K; Abdelhafiz D; Abdelhafiz AH
Postgrad Med; 2021 Nov; 133(8):831-842. PubMed ID: 34126036
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenic obesity in ageing: cardiovascular outcomes and mortality.
Atkins JL; Wannamathee SG
Br J Nutr; 2020 Nov; 124(10):1102-1113. PubMed ID: 32616084
[TBL] [Abstract][Full Text] [Related]
5. Association between sarcopenic obesity and cardiovascular risk: where are we?
Gusmao-Sena MH; Curvello-Silva K; Barreto-Medeiros JM; Da-Cunha-Daltro CH
Nutr Hosp; 2016 Sep; 33(5):592. PubMed ID: 27759996
[TBL] [Abstract][Full Text] [Related]
6. Associations between sarcopenic obesity and risk of cardiovascular disease: A population-based cohort study among middle-aged and older adults using the CHARLS.
Jiang M; Ren X; Han L; Zheng X
Clin Nutr; 2024 Mar; 43(3):796-802. PubMed ID: 38350287
[TBL] [Abstract][Full Text] [Related]
7. Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity.
Wannamethee SG; Atkins JL
Proc Nutr Soc; 2015 Nov; 74(4):405-12. PubMed ID: 25913270
[TBL] [Abstract][Full Text] [Related]
8. The implications of sarcopenia and sarcopenic obesity on cardiometabolic disease.
Kim TN; Choi KM
J Cell Biochem; 2015 Jul; 116(7):1171-8. PubMed ID: 25545054
[TBL] [Abstract][Full Text] [Related]
9. Clinical Implications of Sarcopenic Obesity in Cancer.
Carneiro IP; Mazurak VC; Prado CM
Curr Oncol Rep; 2016 Oct; 18(10):62. PubMed ID: 27541923
[TBL] [Abstract][Full Text] [Related]
10. Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management.
Wei S; Nguyen TT; Zhang Y; Ryu D; Gariani K
Front Endocrinol (Lausanne); 2023; 14():1185221. PubMed ID: 37455897
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of sarcopenic obesity estimated by computed tomography in patients with cardiovascular disease and undergoing surgery.
Yamashita M; Kamiya K; Matsunaga A; Kitamura T; Hamazaki N; Matsuzawa R; Nozaki K; Tanaka S; Nakamura T; Maekawa E; Masuda T; Ako J; Miyaji K
J Cardiol; 2019 Sep; 74(3):273-278. PubMed ID: 30928108
[TBL] [Abstract][Full Text] [Related]
12. Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity.
Chung JY; Kang HT; Lee DC; Lee HR; Lee YJ
Arch Gerontol Geriatr; 2013; 56(1):270-8. PubMed ID: 23079031
[TBL] [Abstract][Full Text] [Related]
13. Sarcopenic obesity in cancer.
Jurdana M; Cemazar M
Radiol Oncol; 2024 Mar; 58(1):1-8. PubMed ID: 38378031
[TBL] [Abstract][Full Text] [Related]
14. Sarcopenic Obesity and Cardiometabolic Health and Mortality in Older Adults: a Growing Health Concern in an Ageing Population.
Wannamethee SG; Atkins JL
Curr Diab Rep; 2023 Nov; 23(11):307-314. PubMed ID: 37566368
[TBL] [Abstract][Full Text] [Related]
15. Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study.
Fukuda T; Bouchi R; Takeuchi T; Tsujimoto K; Minami I; Yoshimoto T; Ogawa Y
Cardiovasc Diabetol; 2018 Apr; 17(1):55. PubMed ID: 29636045
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenic obesity and 10-year cardiovascular disease risk scores in cancer survivors and non-cancer participants using a nationwide survey.
Lee K
Eur J Cancer Care (Engl); 2021 Mar; 30(2):e13365. PubMed ID: 33174666
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress is increased in sarcopenia and associated with cardiovascular disease risk in sarcopenic obesity.
Bellanti F; Romano AD; Lo Buglio A; Castriotta V; Guglielmi G; Greco A; Serviddio G; Vendemiale G
Maturitas; 2018 Mar; 109():6-12. PubMed ID: 29452783
[TBL] [Abstract][Full Text] [Related]
18. Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients.
Anandavadivelan P; Brismar TB; Nilsson M; Johar AM; Martin L
Clin Nutr; 2016 Jun; 35(3):724-30. PubMed ID: 26065721
[TBL] [Abstract][Full Text] [Related]
19. Associations of Sarcopenia and Sarcopenic Obesity With Metabolic Syndrome Considering Both Muscle Mass and Muscle Strength.
Lee J; Hong YP; Shin HJ; Lee W
J Prev Med Public Health; 2016 Jan; 49(1):35-44. PubMed ID: 26841883
[TBL] [Abstract][Full Text] [Related]
20. Impact of sarcopenic obesity on 30-day mortality in critically ill patients with intra-abdominal sepsis.
Ji Y; Cheng B; Xu Z; Ye H; Lu W; Luo X; Fu S; Fang X
J Crit Care; 2018 Aug; 46():50-54. PubMed ID: 29677586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
